References
- Allison AC, Gregoriadis G. Liposomes as immunological adjuvants. Nature 1974; 252: 252
- Belchetz PE, Braidman IP, Crawley JCW, Gregoriadis G. Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: β-glucosidase. Lancet 1977; ii: 116–117
- Gregoriadis G. Drug entrapment in liposomes. FEBS Lett 1973; 36: 292–296
- Gregoriadis G. The carrier potential of liposomes in biology and medicine. New Engl J Med (Medical Progress article) 1976a; 295: 704–710
- Gregoriadis G. The carrier potential of liposomes in biology and medicine. New Engl J Med (Medical Progress article) 1976b; 295: 765–770
- Gregoriadis G, Buckland RA. Enzyme-containing liposomes alleviate a model for storage disease. Nature 1973; 170–172
- Gregoriadis G, Davis C. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Comm 1979; 89: 1287–1293
- Gregoriadis G, Neerunjun DE. Homing of liposomes to target cells. Biochem Biophys Res Comm 1975; 65: 537–544
- Gregoriadis G, Ryman BE. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem 1972; 485–491
- Gregoriadis G, Ryman BE. Lysosomal localization of β–fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders. Biochem J 1972; 129(1)123–133
- Gregoriadis G, Senior J. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation. FEBS Lett 1980; 119: 43–46
- Gregoriadis G, Swain CP, Wills EJ, Tavill AS. Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1974; ii: 1313–1316
- Hwang KJ, Luk KF, Beaumier PL. Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: A kinetic study. Proc Natl Acad Sci U S A 1980; 77(7)4030–4034